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Background: Birthweight is normally determined by a range of 
genetic traits and exposures occurring within the intra-uterine 
environment. Some epidemiological studies have reported high 
birthweight as a risk factor of Acute lymphoblastic Leukemia 
(ALL). Other studies have however not demonstrated this 
relationship. 
Objectives: The objective of this review is to assess the 
association between birthweight and Acute Lymphoblastic 
Leukemia in children. 
Search methods: We searched observational studies from 
Cochrane, MEDLINE, EMBASE, ISI Web of Science, BIOSIS, 
the allied and Complementary Medicine Database and National 
Research Register, ClinicalTrial.gov, WHO International Trials 
Registry Platform. 
Selection criteria: We included case control and cohort studies 
assessing the association between birthweight and ALL in 
children. All participants below the age of 18 years (children) 
with Acute Lymphoblastic Leukemia (ALL) were included in the 
analysis. The independent variable in this review was birth 
weight. Birthweight was categorized into two (2): Birthweight 
>4kg (experimental arm) and ≤4kg (control arm). 
Data collection and analysis: Two reviewers independently 
assessed identified studies through two stages of screening. First, 
titles and abstracts of all references identified through searches 
were screened and irrelevant studies were excluded. Also, full 
texts of potentially eligible studies were further assessed 
according to previously defined inclusion criteria were excluded 
and reasons for their exclusion were stated. All studies that met  
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Leukemia is a heterogeneous group of blood-forming cancers that comprise 
several biologically distinct sub-groups. It accounts for 2.6% of all cancers 
worldwide with 437,033 new cases diagnosed in 2018. (American Institute for 
Cancer Research, 2019) An estimated 176,200 people in the United States were 
expected to be diagnosed with Leukemia, lymphoma and myeloma in 2019, which 
would account for 10% of new cases of cancer (American Cancer Society, 2019). 
Leukemias, the most common cancer in children, account for almost 1 out of 3 
cancers worldwide (Gatta et al., 2014). About 3 out of 4 leukemias in children 
and teens are Acute Lymphocytic Leukemia (ALL; Gatta et al., 2014). 
Several genetic and environmental risk factors have been implicated in the 
pathogenesis of ALL (Petridou et al., 2002). Leukemia development begins with 
cellular mutation, usually chromosomal translocation, during embryogenesis 
(Greaves 2002; Rossig & Juergens, 2008). Cells with certain chromosomal 
translocation such as t(12;21), (4;11) or t(8;21) are frequently found at birth in 
children who later develop leukemia (Greaves, 2005; WIemels et al. 2002). 
Moreover, there is some evidence that perinatal exposures may pose risk for ALL 
in children. A recent meta-analysis of original studies from the Childhood 
the inclusion criteria were included. Areas of disagreement were 
resolved by a third-party review. Two review authors double 
checked the studies independently. 
Main results:Out of the 348 studies screened, 16 of them met the 
inclusion criteria. A total of 3,650,728 participants provided data 
for analysis in this review. These studies were published between 
1987 and 2018. The age span of studies was similar across 
studies (roughly (0-18 years). The vast majority of ALL was 
diagnosed before 15 years. 14 of the included studies were case 
control studies and 2 of them were cohort studies. Figure 1 
presents odd ratio estimates for effect of birthweight on ALL (≤ 
4000g vs. > 4000g). There was a statistically significant positive 
relationship between high birthweight (birthweight > 4000g) 
and risk of ALL (16 studies, OR 0.81, 95% CI 0.77, 0.85). 
Authors' conclusions:Our study revealed a significant positive 
relationship between high birthweight and ALL. Several studies 
have demonstrated an association between factors such as: high 
pre-pregnancy weight and height; gestational age greater than 42 
weeks; parity greater than and high birthweight. Therefore, 
public health programs and interventions aimed at reducing the 
incidence of these maternal factors can reduce the risk of high 
birthweight and lower the incidence of ALL. 
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Leukemia International Consortium have showed positive associations between 
home paint (Bailey et al. 2015), occupational pesticides (Bailey et al. 2014), 
maternal supplementation of folic (Mateyer, 2014) and acute lymphoblastic 
leukemia.  
A commonly investigated risk factor of ALL is birthweight. The observation 
that heavy babies (variously defined as weighing more than 3500g, 4000g and 
4500g) are at risk of developing ALL has received a lot of attention (Johnson, 
Soler, Puumala, Ross & Spector, 2008; Caughey & Michels, 2009; Smith, 
Lightfoot, Simpson, & Roman, 2009). Higher birthweight is associated with 
maternal and fetal hyperglycemia as well as elevated blood insulin levels – all of 
which are factors that are linked with a higher risk of ALL (McLaughlin, 
Baptiste, Schymura, Nasca, & Zdeb, 2006; Caughey & Michels, 2009).  
Some studies have estimated that the risk of ALL increases by 25% for 
children with birthweight of more than 4000g (Hjalgrim et al, 2003). Other 
studies have also reported the following odds ratios per kilogram increase in 
birthweight: 1.45 (Westergaard et al. 1997); 1.29 (Petridou et al. 1997); 1.03 
(Shuz et al 1999) and 1.09 (Shu et al. 2002). The evidence on birthweight and 
ALL has however been inconsistent, with other studies failing to establish 
significant relationship between birthweight and ALL (Reynolds, Behren & Elkin, 
2002; Mckinney et al. 1999; Roman Ansell & Bull, 1997). 
Pooled evidence from various meta-analyses are suggestive of low to moderate 
positive association between ALL and birthweight (Hjalgrim et al, 2003). 
However, the most recent meta-analysis we found was conducted more than a 
decade ago (Caughey & Michels, 2009). In light of recent evidence from empirical 
studies, it is important that this association between birthweight and ALL is re-
examined We therefore, conducted a systematic review of available clinical 
evidence to date to assess the influence of normal and high birthweight on the 





Inclusion and exclusion criteria 
 
We included case control and cohort studies that a) assessed the association 
between birthweight (independent variable) and ALL (outcome variable) b) used 
participants aged below 18 years c) reported the number of ALL cases using two 
categories of birthweight, i.e., >4kg (high) and ≤4kg (normal) based on the 
World Health Organization’s (WHO) classification of birthweight d) were written 
in English. Studies with no abstract were excluded. We also excluded studies that 
reported birthweight as a continuous variable only and not as our predefined 
categories of high and normal birthweight. 
 
Search methods for identification of studies  
 
An electronic search was conducted on 6th October 2019 on the following 
databases: Cochrane, MEDLINE, EMBASE, ISI Web of Science, BIOSIS, the 
allied and Complementary Medicine Database and National Research Register, 
ClinicalTrial.gov, and WHO International Trials Registry Platform. Search terms 
included variants of “acute lymphocytic leukemia OR ALL” AND “birthweight”. 
Full details of search terms can be found in, Table 2. The search strategy was 
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adapted for each electronic database by using database-specific index terms.  We 
also hand-searched reference lists from published studies, bibliographies of 
relevant systematic reviews and grey literature sources such as dissertations, 
theses and google scholar. 
 
Selection of studies  
 
The results of the electronic search were imported into Covidence 
(https://www.covidence.org). Two reviewers (SA and LA) independently assessed 
identified studies through two stages of screening. Firstly, titles and abstracts of 
all references were screened, and irrelevant studies were excluded. Secondly, full 
texts of tentatively eligible studies were further assessed against the pre-defined 
inclusion criteria. Areas of disagreement were resolved through discussions 
between the two reviewers and the reaching of consensus. The use of two 
independent reviewers ensured objectivity and transparency in the selection and 
synthesis of evidence. 
 
Data extraction and risk of bias assessment  
 
Data on study design, sample characteristics, exposure and outcomes were 
extracted independently by the two reviewers using the default data extraction 
form in Covidence. The extracted data were then transferred from Covidence to 
Review Manager 5 software for meta-analysis. We also assessed the 
methodological quality of included studies using the Critical Appraisal Skills 
Program (CASP) for case control and cohort studies as appropriate. The CASP 
checklist for case control and cohort studies are 11- and 12-items checklists that 
enable the reviewer to assess the methodological rigor and validity and reliability 
of evidence from case-control and cohort studies respectively. 
 
Data synthesis  
 
Since all our outcomes were dichotomous, we used odds ratios (OR) as our 
effect measure. Narrative synthesis was used to summarize the key findings of 
included studies. Outcome data from included studies were pooled for meta-
analysis using the fixed effects model. We used the inverse variance method to 
estimate the combined effect size for the outcomes in the meta-analysis. We 
evaluated the statistical heterogeneity in the data using the I2 statistic (Higgins, 
2003). We also evaluated clinical heterogeneity of included studies by assessment 
of study population characteristics. Funnel plots was used to assess reporting 
(publication) bias. We assessed funnel plots visually and used formal tests for 





Results of the search 
 
The search on all electronic databases produced a total of 348 records, of 
which 187 were duplicates. The remaining 169 studies were screened for titles and 
abstracts and 129 records were found ineligible for the review. Sixteen other 
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studies were excluded after full text screening. The remaining 16 studies that met 
the eligibility criteria were included in the current review (Figure 3) 
 
Characteristics of included studies 
 
A total of 3,650,728 participants provided data for analysis in this review. The 
studies originated from the USA (n=9), Australia, Germany, Azerbaijan, 
Denmark, Mexico, Sweden and Brazil. The studies were published between 1987 
and 2018. The age span of studies was similar across studies (roughly 0-18 years). 
The vast majority of ALL was diagnosed before 15 years. Thirteen of the 
included studies were case control studies and 3 of them were cohort studies.  
 
Synthesis of evidence 
 
Figure 1 presents odds ratio estimates for effect of birthweight on ALL (≤ 
4000g vrs > 4000g). All but six of the included studies individually showed a 
statistically significant positive relationship between high birthweight 
(birthweight > 4000g) and ALL. Evidence from the fixed effect meta-analysis 
model suggests 24% higher odds of ALL with children whose birthweight exceeds 
4000g (N=16, OR 1.24, 95% CI 1.18, 1.34). The quality of evidence was rated 
moderate as the average of total for all domains of included studies was 13.5 




We analyzed 16 epidemiologic studies of the association between birthweight 
and Acute Lymphoblastic Leukemia, including information on about 17155 
children with Leukemia. The analysis demonstrated a significant increase of ALL 
in children with high birthweight (≤4000g vrs >4000g), corresponding to an odd 
ratio of 0.81 (CI: 0.77-0.85). The association between birthweight and risk of 
Leukemia was consistently observed in the studies conducted over a period of 
more than 30 years. 
A previous meta-analysis conducted by Hjalgrim et al. (2003) also found a 
similar positive association for high birthweight and Acute Lymphoblastic 
Leukemia, reporting (>4000g vs. ≤ 4000g), odd ratio of 1.26 (CI: 1.17-1.37). Also, 
our result is consistent with the findings of Caughey & Michels, (2009) who found 
a non-significant positive association between high birthweight and ALL in 
children, (OR, 1.23 (95% CI: 1.15, 1.32).  The article by Gholami, 2003 identified 
a relatively strong association between birth weight and ALL risk (corresponding 
to an OR, 0.45, (95% CI: 0.24, 0.86). 
Various studies have shown that genetic events such as chromosomal 
translocation initiated in-utero can lead to acute leukemias (Ford at al., 1993; 
Gill et al. 1994; Wiemels, Ford, Van & Postma, 1999). Ultimately this process 
leads to the uncontrolled proliferation and accumulation of a single clone of 
immature lymphoblasts (Greaves, 1999) Birth weight has been associated with 
several growth factors such as insulin-like growth factor I (IGF I), insulin-like 
growth factor II (IGF-II) and sex-steroid hormones (Michels & Xue, 2006). 
Growth factors may increase the number of stem cells in utero, which increases 
the total number of replicating cells at risk for conversion into tumor cells, 
leading to leukemias (Trichopoulos & Lipworth, .1995). In addition, high 
birthweight resulting from high levels of growth factors in-utero may increase the 
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risk of ALL by inducing proliferative stress on the bone marrow (Ross et al. 1996; 
Albanes & Winick, 1988). 
In summary, this study confirms previously reported evidence of a positive 
association between high birth weight and overall leukemia risk. This result 
emphasizes the need for studies to clarify the biologic mechanisms underlying the 





Our study revealed a significant positive relationship between high 
birthweight and ALL. Several studies have demonstrated an association between 
factors such as: high pre-pregnancy weight and height (Janne, Tine, Ulrik & 
Niels, 2003); gestational age greater than 42 weeks (Ceska, 2005); parity greater 
than 2 (Wikstrom, Axelsson , & Bergstrom, 1991) and high birthweight. 
Therefore, public health programs and interventions aimed at reducing the 
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Figures 
 
Forest plot of comparison: 1 >4000g vs ≤4000g, outcome: 1.2 New Outcome. 
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NB: Yes= 1, No = 0, Average of all domains of included studies = 13.5 
 
 
Table 2. List and Combination of Search Terms 
1.  Acute 
2.  Leukemia 
3.  Lymphocytic 
4.  Birth 
5.  Children 
6.  Weight 
7.  Systematic review 
8.  Lymphoma 
9.  Myeloma 
10.  Infants 
11.  Childhood 
12.  Observational 
13.  Case-controlled 
14.  Cross-sectional studies 
15.  1+3+2+5+6 
16.  2+5+4+6 
 
Reliable compliance? N/A N/A N/A N/A N/A N/A N/A N/A 
Accurate outcome 
measures? 
Yes Yes Yes Yes Yes Yes Yes Yes 
Same population? Yes Yes Yes Yes Yes Yes Yes Yes 
Participants recruited 
at the same time? 
Yes Yes Yes Yes Yes Yes Yes Yes 
Randomised? Yes Yes Yes Yes Yes No Yes No 
Adequate allocation 
concealment? 
No Yes Yes Yes Yes No Yes No 
Adequate adjustment 
for confounders? 
Yes Yes Yes Yes Yes No No Yes 
Loss of follow up 
reported? 
No No Yes No No No No No 
Power calculation? Yes Yes No No No No No No 
Total score: (sum of all 
domains) 
15 17 18 15 15 12 15 13 
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17.  4+7+11 
18.  3 or 2 or 5 or 12 
19.  6 or 9 or 5 or 4 
 
 
Characteristics of studies  
 
Characteristics of included studies 
 
Barahmani 2015 
Methods Study design: Case control study 
Study grouping: Case and control 
Participants Baseline Characteristics 
Included criteria: . The authors compared birth certificate data of 575 children 
diagnosed with ALL who were younger than 5 years and included in the Texas Cancer 
Registry, Texas Department of Health, between the years 1995 and 2003 with 11,379 
controls matched by birth year. 
Excluded criteria: Gestational age (GA) and/or BW missing or if BW was less than 500 
g 
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous outcome 
Reporting: Fully reported 
Direction: Lower is better 
Identification Sponsorship source: Not reported 
Country: United States of America 
Setting: Texas Department of State Health Services 
Comments: 
Authors name: Nadia Barahmani,Tevfik Dorak, Michele R. Forman, Michael Sprehe, 
Michael E. Scheurer, Melissa L. Bondy, Fatih Okcu,and Philip J. Lupo 
Institution: Department of Pediatrics, Baylor College of Medicine, Texas Children’s 
Cancer Center, Houston, Texas, USA; 2Childhood Cancer Prevention and Epidemiology 
Center, Houston, Texas, USA; 
Email: Philip.Lupo@bcm.edu 
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Crump 2015 
Methods Study design: Cohort study  
Participants Baseline Characteristics 
Included criteria: Individuals in the Swedish Birth Registry who were born from 1973 
through 2008 
Excluded criteria: Individuals with Down syndrom, others who had missing information 
for birth weight, and others who had missing information for gestational age at birth.  
Pretreatment: 
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous outcome 
Identification Sponsorship source: This work was supported by the National Cancer Institute at the 
National Institutes of Health [grant number R03 CA171017]; the Swedish Research 
Council; and ALF project grant, Region Skåne/Lund University, Sweden. 
Country: Sweden 
Setting: Center for Primary Health Care Research, Lund University, Malmö, Sweden 
Authors name: Casey Crump, Jan Sundquist, Weiva Sieh, Marilyn A. Winkleby, and 
Kristina Sundquist. 
Institution: Center for Primary Health Care Research, Lund University, Malmö, Sweden 
Email: kccrump@stanford.edu. 
Address: Stanford University, Department of Medicine, 211 Quarry Road, Suite 405, 




Methods Study design: Case control study 
Study grouping: Participants with ALL and those without ALL 
Participants Baseline Characteristics 
Included criteria: Patients with acute leukaemia, diagnosed from 20 March 2003 and 20 
March 2009, age less than 15 years at the time of diagnosis and residing in West 
Azerbaijan province at the time of diagnosis 
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous outcome 
Identification Sponsorship source: National Cancer Institute at the National Institutes of Health [grant 
number R03 CA171017]; the Swedish Research Council; and ALF project grant, Region 
Skåne/Lund University, Sweden 
Country: Sweden 
Setting: Swedish Birth Registry 
Authors name: Casey Crump, Jan Sundquist, Weiva Sieh, Marilyn A. Winkleby, and 
Kristina Sundquist. 
Institution: Center for Primary Health Care Research, Lund University, Malmö, Sweden 
Email: kccrump@stanford.edu 
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Address: Stanford University, Department of Medicine, 211 Quarry Road, Suite 405, 




Methods Study design: Case Controlled study  
Study grouping: Case and control 
Participants Baseline Characteristics 
Included criteria: Patients who have been diagnosed with Acute Lymphoblastic 
Leukemia 
Excluded criteria: Patients with down syndrome 
Pretreatment: 
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous outcome 
Identification Sponsorship source: Not stated 
Country: Denmark 
Setting: Danish Epidemiology Science Center, Statens Serum Institut, Copenhagen, 
Denmark. 
Authors name: Lisa Lyngsie Hjalgrim, Klaus Rostgaard, Henrik Hjalgrim, Tine 
Westergaard, Harald Thomassen, Erik Forestier, Göran Gustafsson, Jon Kristinsson, 
Mads Melbye, Kjeld Schmiegelow. 
Institution: Department of Epidemiology Research, Danish Epidemiology Science 
Center, Statens Serum Institut, Copenhagen, Denmark. 
Email: : lih@ssi.dk. 
Address: Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, 
2300 Copenhagen S, Denmark 
Notes  
 
Jimnez Hernndez 2018 
Methods Study design: Case-control study 
Study grouping:  
Participants Baseline Characteristics 
Included criteria: incident cases with acute lymphoblastic leukemia (ALL) diagnosed 
between 2010 and 2015. 
Excluded criteria: Not indicated 
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous outcome 
Identification Sponsorship source: Consejo Nacional de Ciencia y Tecnologia [grant numbers: SALUD-
2010-1-141026, FIS/ IMSS/PROT/895; PDCPN2013-01-215726, 
FIS/IMSS/PROT/1364; SALUD 2015-1- 262190, FIS/IMSS/PROT/1533 and CB-2015-
1-258042, FIS/IMSS/PROT/1548] and by the Instituto Mexicano del Seguro Social 
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[grant numbers: FIS/IMSS/PROT/ PRIO/11/017, FIS/IMSS/PROT/G12/1134. 
Country: Mexico 
Setting: Public hospitals of Mexico City 
Authors name: Elva Jiménez-Hernández, Arturo Fajardo-Gutiérrez, Juan Carlos Núñez-
Enriquez, Jorge Alfonso Martín-Trejo, Laura Eugenia Espinoza-Hernández. 
Institution: Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico 
Email: juan.mejiaa@imss.gob.mx 




Methods Study design: Case-controlled study 




Included criteria: Patients diagnosed with Acute Lymphoblastic Leukemia whose 
birthweights are available. 
Excluded criteria: Cases with no birthweight record 
Pretreatment: 
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous outcome 
Identification Sponsorship source: Not stated 
Country: Brasil 
Setting: Different hospitals in Brasil 
Authors name: S Koifman1 and M.S Pombo-de-Oliveira  
Institution: Divisa˜o de Medicina Experimental, Centro de Pesquisa – Instituto Nacional 





McLaughlin 2006  
Methods Study design: Cohort study 
Study grouping: 
Participants Baseline Characteristics 
Included criteria: All cases age 1 month to 9 years diagnosed with acute leukemia 
between 1985 and 2001 while resident of New York State and born in New York State 
Excluded criteria: Cases born in New York city  
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous outcome 
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Identification Sponsorship source: Not reported 
Country: United States of America 
Setting: e New York State Cancer Registry 
Comments: 
Authors name: CC McLaughlin, MS Baptiste,MJ Schymura, PC Nasca4 and MS Zdeb 
Institution: New York State Cancer Registry, New York State Department of Health. 
Email: ccm01@health.state.ny.us 
Address: Empire State Plaza, Albany, NY 12237-0679, USA. 
Notes  
 
Milne 2009  
Methods Study design: Case-control study 
Participants Baseline Characteristics  
Included criteria: Cases (Acute Lymphoblastic Leukemia patients) were eligible to 
participate if they were diagnosed between July 1, 2003, and December 31, 2006 
Excluded criteria: Children with birth defects—including Down syndrome. 
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous outcome 
Identification Sponsorship source: Australian National Health and Medical Research Council (grant ID 
254539). E. Milne is supported by an NHMRC Career Development Award and Cancer 
Council Western Australia Research Fellowship. B. Armstrong’s research is supported 
by a University of Sydney Medical Foundation Program Grant. H. Bailey is supported 
by an NHMRC PhD Scholarship. 
Country: Australia 
Setting: oncology centers in Australia, where virtually all children with ALL are treated 
Comments:  
Authors name: E. Milne, J. A. Royle, N. H. de Klerk, E. Blair, H. Bailey, C. Cole, J. 
Attia, R. J. Scott, and B. K. Armstrong  
Institution: Telethon Institute for Child Health Research 
Email: lizm@ichr.uwa.edu.au) 




Okcu 2002  
Methods Study design: Case-controlled study 
Study grouping: 




Included criteria: children younger than five years of age who were residents of Texas, 
diagnosed with cancer in 1995 and registered bythe Texas Cancer Registry (TCR) of the 
Texas Department of Health (TDH). 
Excluded criteria: Birthweights less than 1000g 
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Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous outcome 
Identification Sponsorship source: Not reported 
Country: USA 
Setting: Texas Cancer Registry (TCR) of the Texas Department of Health (TDH). 
Comments: 
Authors name: Mehmet Fatih Okcu, Karen J. Goodman, Susan E. Carozza, Nancy S. 
Weiss, Keith D. Burau, W. Archie Bleyer & Sharon P. Cooper 
Institution: Division of Pediatrics, University of Texas 
Email: fokcu@mdanderson.org 
Address: Division of Pediatrics, Box 087, University of Texas M.D. Anderson Cancer 
Center, Houston, TX 77030, USA. 
Notes  
 
Oksuzyan 2012  
Methods Study design: Case-controlled study 
Study grouping: 
Participants Baseline Characteristics 
Included criteria: Childhood leukemia cases diagnosed between 1988 and 2008 in 
children younger than 16 years who were born in California and resided in California at 
the time of diagnosis  
Excluded criteria: Not reported 
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous outcome 
Identification Sponsorship source: Not reported 
Country: USA 
Setting: California Cancer Registry 
Authors name: S. Oksuzyan, C.M. Crespi b , M. Cockburn, G. Mezei d , L. Kheifets. 




Ou 2002  
Methods Study design: Case-control study 
Participants Baseline Characteristics 
1842 ALL cases (age <15 years) 
Included criteria:  1842 ALL cases (age <15 years) 
Excluded criteria: Ineligible matched case  
Interventions Intervention Characteristics 
≤4000g 
>4000g 
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Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous Outcome 
Identification Sponsorship source: University of Minnesota Children’s Research Fund and grants no. 
CA49450 and CA58051 from the National Cancer Institute. 
Country: USA 
Setting: California  
Authors name: Xiao Ou Shu, Dehui Han, Richard K. Severson, Zhi Chen, Joseph P. 
Neglia, Gregory H. Reaman , Jonathan D. Buckley & Leslie L. Robison 
Institution: Children Cancer Group 
Email: Address: XiaoOu.Shu@mcmail. vanderbilt.edu 
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Podvin 2006  
Methods Study design: Case-controlled study 
Study grouping:  
Participants Baseline Characteristic 
Included criteria: Children , 20years diagnosed with ALL 
Excluded criteria: Infants with Down’s syndrome 
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia Outcome type: Dichotomous Outcome 
Identification Sponsorship source: Cancer Surveillance System of the Fred Hutchinson Cancer 
Research Center 
Country: United States of America 
Setting: Washington State Cancer Registry 
Comments:  
Authors name: Danise Podvina, Carrie M. Kuehna, Beth A. Muellera, and Michelle 
Williams 
Institution: University of Washington, Department of Rehabilitation Medicine, Centre 
for Technology and Disability Studies 
Email: cmkuehn@u.washington.edu 




Reynolds 2002  
Methods Study design: Case -controlled study 
Participants Baseline Characteristics 
Included criteria: leukemia cases were diagnosed in children under age 5 years between 
1988 and 1997. 
Excluded criteria: Children with down syndrome, twins and triplets. 
Pretreatment:  
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
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Outcome type: Dichotomous Outcome 
Identification Sponsorship source: National Cancer Institute. 
Country: United States of America 
Setting: California Cancer Registry  
Authors name: Peggy Reynolds, Julie Von Behren, and Eric P. Elkin 
Institution: California Cancer Registry 
Email: Preynold@dhs.ca.gov) 
Address: 1515 Clay Street, 17th Floor, Oakland, CA 94612 
Notes  
 
Robison 1987  
Methods Study design: Case-Controlled study 




Included criteria: All cases of ALL diagnosed since January 1969 
Excluded criteria: Weights <2000g 
Pretreatment:  
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous Outcome 
Identification Sponsorship source: University of Minnesota Computer Center, and the Children's 
Cancer Research Fund. 
Country: USA 
Setting: University of Minnesota and the Mayo Clinic 
Authors name: Leslie Robison, Mary Codd and Paul Gunderson 
Institution: University of Minnesota Health Sciences Center 
Email: Not reported 
Address: Minneapolis, Minnesota 55455, U.S.A 
Notes  
 
Schz 2007  
Methods Study design: Case-controlled study  
Participants Baseline Characteristics 
Included criteria: Cases of ALL diagnosed in children <14 years who have lived in West 
Germany at the age of diagnosis. 
Excluded criteria: Children with down syndrome 
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous outcome 
Identification Sponsorship source: Intramural Research Program of the NIH, National Cancer 
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Institute, and by The Danish Cancer Society 
Country: Germany  
Setting: German Childhood Cancer Registry (GCCR) at the University of Mainz. 
Authors name: Joachim Schuz, Michele R. Forman 
Institution: University of Mainz 
Email: Joachim@cancer.dk 
Address: Strandboulevarden 49, 2100 Copenhagen, Denmark. 
Notes  
 
Sprehe 2010  
Methods Study design: Case-controlled study 
Participants Baseline Characteristics 
Included criteria: all children that were singleton births and aged <5 years, who were 
residents of Texas, and had gestational age data, as well as diagnosed with a malignancy 
between 1995 and 2003 
Excluded criteria: Birthweight (BW) was missing; if the BW was , 500g or if conditions 
diagnosed at birth were likely to cause death during infancy. 
Pretreatment:  
Interventions Intervention Characteristics 
≤4000g 
>4000g 
Outcomes Acute Lymphoblastic Leukemia 
Outcome type: Dichotomous outcome 
Identification Sponsorship source: National Cancer Institute training grant R25 CA57730 
Country: USA 
Setting: Texas Department of Health  
Authors name: Michael R. Sprehe, Nadia Barahmani, Yumei Cao, Tao Wang, Michele 
R. Forman, Melissa Bondy, and M. Fatih Okcu,  
Institution: Texas Department of Health 
Email: mfokcu@txccc.org 




Characteristics of excluded studies  
 
Buckley 1994  
Reason for exclusion Wrong study design 
Chokkalingam 2012  
Reason for exclusion Wrong outcomes 
Cnattingius 1995  
Reason for exclusion Wrong outcomes 
Dorak 2007  
Reason for exclusion Wrong outcomes 
Glinianaia 2011  
Reason for exclusion Wrong outcomes 
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Groves 2018  
Reason for exclusion Wrong intervention 
Gruhn 2008  
Reason for exclusion Wrong outcomes 
Johnson 2008  
Reason for exclusion Wrong outcomes 
Kennedy 2015  
Reason for exclusion No full-text 
Murray 2002  
Reason for exclusion Wrong intervention 
ONeill 2012  
Reason for exclusion Wrong outcomes 
Paltiel 2015  
Reason for exclusion Wrong outcomes 
Rafieemehr 2019  
Reason for exclusion Wrong intervention 
Roman 2013  
Reason for exclusion Wrong intervention 
Westergaard 1997  
Reason for exclusion Wrong intervention 
Yeazel 1997  
Reason for exclusion Wrong intervention 
 
